These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 186345)

  • 1. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
    Morita S; Doi K; Yip CC; Vranic M
    Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.
    Doi K; Prentki M; Yip C; Muller WA; Jeanrenaud B; Vranic M
    J Clin Invest; 1979 Mar; 63(3):525-31. PubMed ID: 429572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of immunoreactive glucagon fractions of canine stomach and pancreas.
    Srikant CB; McCorkle K; Unger RH
    J Biol Chem; 1977 Mar; 252(6):1847-51. PubMed ID: 191445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adrenergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs.
    Yoshida T; Kondo M
    Diabetes; 1980 May; 29(5):355-60. PubMed ID: 6103854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric A-cell function in insulin-deprived depancreatized dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
    Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Gastroenterol Jpn; 1980; 15(3):241-6. PubMed ID: 7399222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution of glucagon, glucagonlike immunoreactivity, and insulin in the rat.
    Perez-Castillo A; Blázquez E
    Am J Physiol; 1980 Mar; 238(3):E258-66. PubMed ID: 6989265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gastric glucagon immunoreactivity in pancreatectomized dogs.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Jpn J Surg; 1980 Sep; 10(3):255-60. PubMed ID: 7012409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glucagon in the gastrointestinal tract.
    Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
    J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive glucagon in the vascular walls of the rat.
    Tanaka J; Shiosaka S; Tsubouchi H; Gohda E; Daikuhara Y; Tohyama M
    Life Sci; 1983 Oct; 33(16):1599-604. PubMed ID: 6355735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic extraction of plasma immunoreactive glucagon components. Predilection for 3500-dalton glucagon metabolism by the liver.
    Jaspan JB; Polonsky KS; Röjdmark S; Ishida T; Field JB; Rubenstein AH
    Diabetes; 1981 Sep; 30(9):767-72. PubMed ID: 7262472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.